Sotyktu Coupon & Prices
Complete a free online enrollment application to find out if you’re eligible to pay only $49 per month for your Sotyktu medication with our help.Get Started Now
Secure: Your personal and medical information is safe with us
Convenient: Your medication is delivered straight to your door
Ongoing refills: Your medication is refilled automatically
NiceRx works with your healthcare provider to help you access affordable medications directly from U.S. pharmaceutical companies.
How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Sotyktu cost savings if eligible
With our assistance, you could access the Sotyktu patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Sotyktu patient assistance?
We review each Sotyktu enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Sotyktu patient assistance program?
Our process makes it as easy as possible to apply for the Sotyktu patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Sotyktu, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Sotyktu coupons provider?
NiceRx is not a Sotyktu coupon, Sotyktu discount card, or Sotyktu copay card provider. We do not offer Sotyktu manufacturer coupons, Sotyktu discounts, rebates, Sotyktu savings cards, trial offers, or free Sotyktu samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me get Sotyktu cheaper if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Sotyktu
- Your insurance company will not pay for your Sotyktu prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Sotyktu cost without insurance?
Without insurance, Sotyktu costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Sotyktu will cost around $6,200 for a 30 day supply.
How much does Sotyktu cost with insurance?
The copay for Sotyktu will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Sotyktu?
Sotyktu is an FDA-approved (U.S. Food and Drug Administration) medication manufactured by Bristol Myers Squibb (BMS). Sotyktu is a tyrosine kinase 2 (TYK2) inhibitor for the treatment of adults with moderate-to-severe plaque psoriasis who are appropriate candidates for systemic therapy or phototherapy. It is not recommended for use with other potent immunosuppressants.
Approval of Sotyktu was based on results from the POETYK PSO-1 and POETYK PSO-2 clinical trials, which demonstrated superior efficacy of once-daily Sotyktu compared to placebo and twice-daily Otezla (apremilast) in patients aged 18 years and older. Patient responses were evaluated using the Psoriasis Area and Severity Index (PASI 75) and the Physician’s Global Assessment (sPGA) score.
Sotyktu is an alternative to biologic drugs such as Humira and Amgen’s Enbrel as well as topical and conventional treatments. As a pill it will be more convinient to use for patients who don’t want to use injectable medicines on a regular basis. Bristol Myers is currently testing Sotyktu for psoriatic arthritis and Crohn’s disease,
What doses of Sotyktu are available?
Sotyktu is available in tablet form, in the following doses: 6 mg.
The recommended dose is 6 mg orally once daily, with or without food. Please see the full prescribing information and always speak with your healthcare provider about any changes to your dose so they can monitor and evaluate your condition.
Sotyktu active ingredients
The active ingredient of Sotyktu is deucravacitinib, a tyrosine kinase 2 (TYK2) inhibitor. The exact mechanism of action linking inhibition of TYK2 enzyme to therapeutic effectiveness in the treatment of adults with moderate-to-severe plaque psoriasis is unknown, but may be associated with the potential adverse reactions of Janus Kinase (JAK) inhibition.
Sotyktu side effects
The most common side effects caused by Sotyktu in clinical trials compared to placebo include:
- Upper respiratory infections
- Blood creatine phosphokinase increased
- Herpes simplex
- Mouth ulcers
In rare instances, Sotyktu can cause more serious side effects. These can include:
- Increased risk of infections
- Laboratory abnormalities
- Potential risks may be related to Sotyktu being a JAK inhibitor. Risks include sudden cardiovascular death, major adverse cardiovascular events, overall thrombosis, deep venous thrombosis, pulmonary embolism, and malignancies
Your doctor will assess the benefits of using Sotyktu against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Sotyktu to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Sotyktu drug interactions
Other drugs may interact with Sotyktu, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medications including any supplements you are taking.
You should not use Sotyktu if you:
- Are allergic to the active ingredient deucravacitinib
- Are allergic to any of the other ingredients in Sotyktu
- Have severe hepatic impairment (Child-Pugh C)
Talk to your doctor before using Sotyktu if you:
- Are taking any of the medications that could interact with Sotyktu
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Sotyktu is the trademark brand name for deucravacitinib manufactured by Bristol Myers Squibb. A generic version of deucravacitinib is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Sotyktu savings through NiceRx.
*Qualifying persons may obtain medications directly from patient assistance programs without any out-of-pocket cost (or for less than $49 per medication). However, our monthly flat rate of just $49 per medication spares you the hassle of tracking the different programs and filling out all the required paperwork for each program. Subject to medication availability and acceptance by the pharmaceutical companies. NiceRx is not responsible for any delays or rejection by the pharmaceutical companies.
Enrollees enjoy a full-service solution, as NiceRx assists them and their physicians with the entire process. We prepare all required documents for the physician to sign, help enrollees manage all prescription refills, monitor eligibility criteria, and maintain enrollment.
**If you do not receive medications because you were determined to be ineligible for the prescription assistance by the applicable pharmaceutical companies and you have a letter of denial, we will refund any fees you paid toward medications for which you did not qualify to receive prescription assistance (“Refund”).
To receive a refund, you must send the letter of denial to us by fax to 888-517-7444, or by e-mail to [email protected] within 30 days of your receipt of such letter. The Refund is your sole and exclusive remedy for any fees you may wish to dispute.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.